+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Prefusion-stabilized Hendra virus fusion protein | |||||||||
Map data | Prefusion-stabilized Hendra virus fusion protein | |||||||||
Sample |
| |||||||||
Keywords | Hendra / nipah / henipavirus / Hendra virus / NiV / HeV / fusion / F / antibody / neutralizing / conserved epitope / neutralizing antibody / prefusion / prefusion-stabilized / vaccine / vaccine design / antigen / antigen design / VIRAL PROTEIN | |||||||||
| Function / homology | Function and homology informationhost cell surface / fusion of virus membrane with host plasma membrane / viral envelope / symbiont entry into host cell / host cell plasma membrane / virion membrane / membrane Similarity search - Function | |||||||||
| Biological species | Hendra henipavirus | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.8 Å | |||||||||
Authors | Byrne PO / Blade EG / McLellan JS | |||||||||
| Funding support | United States, 1 items
| |||||||||
Citation | Journal: J Virol / Year: 2024Title: Prefusion stabilization of the Hendra and Langya virus F proteins. Authors: Patrick O Byrne / Elizabeth G Blade / Brian E Fisher / David R Ambrozak / Ajit R Ramamohan / Barney S Graham / Rebecca J Loomis / Jason S McLellan / ![]() Abstract: Nipah virus (NiV) and Hendra virus (HeV) are pathogenic paramyxoviruses that cause mild-to-severe disease in humans. As members of the genus, NiV and HeV use an attachment (G) glycoprotein and a ...Nipah virus (NiV) and Hendra virus (HeV) are pathogenic paramyxoviruses that cause mild-to-severe disease in humans. As members of the genus, NiV and HeV use an attachment (G) glycoprotein and a class I fusion (F) glycoprotein to invade host cells. The F protein rearranges from a metastable prefusion form to an extended postfusion form to facilitate host cell entry. Prefusion NiV F elicits higher neutralizing antibody titers than postfusion NiV F, indicating that stabilization of prefusion F may aid vaccine development. A combination of amino acid substitutions (L104C/I114C, L172F, and S191P) is known to stabilize NiV F in its prefusion conformation, although the extent to which substitutions transfer to other henipavirus F proteins is not known. Here, we perform biophysical and structural studies to investigate the mechanism of prefusion stabilization in F proteins from three henipaviruses: NiV, HeV, and Langya virus (LayV). Three known stabilizing substitutions from NiV F transfer to HeV F and exert similar structural and functional effects. One engineered disulfide bond, located near the fusion peptide, is sufficient to stabilize the prefusion conformations of both HeV F and LayV F. Although LayV F shares low overall sequence identity with NiV F and HeV F, the region around the fusion peptide exhibits high sequence conservation across all henipaviruses. Our findings indicate that substitutions targeting this site of conformational change might be applicable to prefusion stabilization of other henipavirus F proteins and support the use of NiV as a prototypical pathogen for henipavirus vaccine antigen design.IMPORTANCEPathogenic henipaviruses such as Nipah virus (NiV) and Hendra virus (HeV) cause respiratory symptoms, with severe cases resulting in encephalitis, seizures, and coma. The work described here shows that the NiV and HeV fusion (F) proteins share common structural features with the F protein from an emerging henipavirus Langya virus (LayV). Sequence alignment alone was sufficient to predict which known prefusion-stabilizing amino acid substitutions from NiV F would stabilize the prefusion conformations of HeV F and LayV F. This work also reveals an unexpected oligomeric interface shared by prefusion HeV F and NiV F. Together, these advances lay a foundation for future antigen design targeting henipavirus F proteins. In this way, Nipah virus can serve as a prototypical pathogen for the development of protective vaccines and monoclonal antibodies to prepare for potential henipavirus outbreaks. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_27577.map.gz | 97.1 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-27577-v30.xml emd-27577.xml | 17.4 KB 17.4 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_27577_fsc.xml | 9.9 KB | Display | FSC data file |
| Images | emd_27577.png | 75.6 KB | ||
| Masks | emd_27577_msk_1.map | 103 MB | Mask map | |
| Filedesc metadata | emd-27577.cif.gz | 5.7 KB | ||
| Others | emd_27577_additional_1.map.gz emd_27577_half_map_1.map.gz emd_27577_half_map_2.map.gz | 51.6 MB 95.6 MB 95.6 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-27577 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-27577 | HTTPS FTP |
-Validation report
| Summary document | emd_27577_validation.pdf.gz | 934 KB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_27577_full_validation.pdf.gz | 933.6 KB | Display | |
| Data in XML | emd_27577_validation.xml.gz | 18.4 KB | Display | |
| Data in CIF | emd_27577_validation.cif.gz | 23.6 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-27577 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-27577 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 8dnrMC ![]() 8dngC ![]() 8do4C ![]() 8u1rC C: citing same article ( M: atomic model generated by this map |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_27577.map.gz / Format: CCP4 / Size: 103 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Prefusion-stabilized Hendra virus fusion protein | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.94 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Mask #1
| File | emd_27577_msk_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Additional map: Additional Map
| File | emd_27577_additional_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Additional Map | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: Half Map 1
| File | emd_27577_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half Map 1 | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: Half Map 2
| File | emd_27577_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half Map 2 | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Prefusion-stabilized Hendra virus fusion protein
| Entire | Name: Prefusion-stabilized Hendra virus fusion protein |
|---|---|
| Components |
|
-Supramolecule #1: Prefusion-stabilized Hendra virus fusion protein
| Supramolecule | Name: Prefusion-stabilized Hendra virus fusion protein / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1 |
|---|---|
| Source (natural) | Organism: Hendra henipavirus |
-Macromolecule #1: Fusion glycoprotein F0
| Macromolecule | Name: Fusion glycoprotein F0 / type: protein_or_peptide / ID: 1 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Hendra henipavirus / Strain: isolate Horse/Autralia/Hendra/1994 |
| Molecular weight | Theoretical: 48.721742 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: GILHYEKLSK IGLVKGITRK YKIKSNPLTK DIVIKMIPNV SNVSKCTGTV MENYKSRLTG ILSPIKGAIE LYNNNTHDCV GDVKLAGVC MAGIAIGIAT AAQITAGVAL YEAMKNADNI NKLKSSIEST NEAVVKLQET AEKTVYVFTA LQDYINTNLV P TIDQIPCK ...String: GILHYEKLSK IGLVKGITRK YKIKSNPLTK DIVIKMIPNV SNVSKCTGTV MENYKSRLTG ILSPIKGAIE LYNNNTHDCV GDVKLAGVC MAGIAIGIAT AAQITAGVAL YEAMKNADNI NKLKSSIEST NEAVVKLQET AEKTVYVFTA LQDYINTNLV P TIDQIPCK QTELALDLAL SKYLSDLLFV FGPNLQDPVS NSMTIQAISQ AFGGNYETLL RTLGYATEDF DDLLESDSIA GQ IVYVDLS SYYIIVRVYF PILTEIQQAY VQELLPVSFN NDNSEWISIV PNFVLIRNTL ISNIEVKYCL ITKKSVICNQ DYA TPMTAS VRECLTGSTD KCPRELVVSS HVPRFALSGG VLFANCISVT CQCQTTGRAI SQSGEQTLLM IDNTTCTTVV LGNI IISLG KYLGSINYNS ESIAVGPPVY TDKVDISSQI SSMNQSLQQS K UniProtKB: Fusion glycoprotein F0 |
-Macromolecule #2: 2-acetamido-2-deoxy-beta-D-glucopyranose
| Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 2 / Number of copies: 12 / Formula: NAG |
|---|---|
| Molecular weight | Theoretical: 221.208 Da |
| Chemical component information | ![]() ChemComp-NAG: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Buffer | pH: 8 |
|---|---|
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
| Microscope | TFS GLACIOS |
|---|---|
| Image recording | Film or detector model: FEI FALCON IV (4k x 4k) / Average electron dose: 44.0 e/Å2 |
| Electron beam | Acceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.5 µm / Nominal defocus min: 1.5 µm |
Movie
Controller
About Yorodumi




Keywords
Hendra henipavirus
Authors
United States, 1 items
Citation












Z (Sec.)
Y (Row.)
X (Col.)




















































Homo sapiens (human)
Processing
FIELD EMISSION GUN
